BIOTECHNOLOGY ULTRASECTOR Maximum Drawdown
| BIPIX Fund | | | USD 75.48 -3.45 -4.37% |
Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough. Below is BIOTECHNOLOGY ULTRASECTOR's current Maximum Drawdown with peer comparisons and related risk metrics.
Current Maximum Drawdown Value
A Maximum Drawdown of 14.31 for BIOTECHNOLOGY ULTRASECTOR signals a moderate peak-to-trough loss. This places BIOTECHNOLOGY ULTRASECTOR's drawdown exposure within the typical range for ProFunds Funds.
Maximum Drawdown | = | MAX(HIGH - LOW) |
| = | 14.31 | |
| MAX | = | Maximum notation for the range of returns on BIOTECHNOLOGY ULTRASECTOR |
Maximum Drawdown Peers Comparison
Relative to peers, BIOTECHNOLOGY ULTRASECTOR's Maximum Drawdown is above the group average of 6.04. Peer readings range from 2.86 (Columbia Adaptive Risk) to 14.32 (Biotechnology Ultrasector Profund), reflecting wide dispersion across the sector. BIOTECHNOLOGY ULTRASECTOR's deeper drawdown relative to peers indicates greater historical downside exposure.
Maximum Drawdown Relative To Other Indicators
The chart below plots Maximum Drawdown against Maximum Drawdown for Biotechnology Ultrasector and its peers. Each point represents one equity — position along the horizontal axis shows Maximum Drawdown while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
BIOTECHNOLOGY ULTRASECTOR's Maximum Drawdown of
14.31 runs about
1.00 times its Maximum Drawdown of
14.31 . The two measures are closely aligned in magnitude for BIOTECHNOLOGY ULTRASECTOR.
Methodology, Assumptions & Data Sources
The current Maximum Drawdown for BIOTECHNOLOGY ULTRASECTOR is 14.31. The Maximum Drawdown for BIOTECHNOLOGY ULTRASECTOR applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. BIOTECHNOLOGY ULTRASECTOR operates in the trading--leveraged equity sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators